Tag Archives: tranparency

Pharma's Transparency Troubles

Transparency Troubles for Pharma High prices, murky financial relations, and a reluctance to disclose clinical data are undermining public trust in industry and the research enterprise, writes Jill Wechsler It seems like open season on the pharmaceutical industry. Academics and consumer activists charge pharma companies with hiding clinical trial information on medical product safety, fueling […]
Posted in Europe, FDA, Guest Blog, Op-Ed, Regulatory | Also tagged , , , , | Leave a comment

New Transparency in UK Pharma: A Bitter Pill to Swallow?

In November 2010, members of the Association of the British Pharmaceutical Industry (ABPI) voted in favour of changes to its Code of Practice, with a view to breaking down ‘barriers to trust’ between healthcare professionals and the pharma. The amendments apply to clauses regarding consultant payments and meeting sponsorship. Under the new 2011 Code, pharma […]
Posted in compliance, Europe, Global, healthcare, Regulatory | Also tagged , , , , | Leave a comment

Wins and Losses from Risk-Sharing Agreements

Can you manage the external market impact? Risk-sharing agreements – where companies contract with reimbursement or assessment authorities to guarantee a new drug’s performance, often against specific outcomes measures, in return for access to patients – are among the latest innovations in managing health care costs. Use of the tool is standard in Australia, is […]
Posted in Europe, Global, healthcare, pricing, Regulatory, Strategy | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta